Geneos Wealth Management’s NCR Atleos NATL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$23.5K Buy
521
+47
+10% +$2.17K ﹤0.01% 2035
2026
Q2
$20.6K Buy
474
+26
+6% +$1.15K ﹤0.01% 1787
2026
Q1
$19.5K Hold
448
– – ﹤0.01% 1779
2025
Q4
$17.1K Hold
448
– – ﹤0.01% 1791
2025
Q3
$17.6K Sell
448
-68
-13% -$2.37K ﹤0.01% 1770
2025
Q2
$14.7K Buy
516
+176
+52% +$4.75K ﹤0.01% 2164
2025
Q1
$8.97K Buy
340
+17
+5% +$505 ﹤0.01% 2305
2024
Q4
$11K Buy
+323
New +$9.8K ﹤0.01% 2017

Other funds holding NATL

Geneos Wealth Management's NATL Position: Q3 2026 in Review

Geneos Wealth Management increased its NCR Atleos (NATL) stake by 9.9% in Q3 2026, buying an estimated $2.17K and bringing the position to 521 shares worth $23.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2035.

Geneos Wealth Management first reported a position in NATL in Q4 2024 and has held it in 8 quarters since. 284 funds tracked by Wall St. Rank hold NATL as of Q3 2026.

  • Geneos Wealth Management held 521 shares of NCR Atleos worth $23.5K as of Q3 2026.
  • Geneos Wealth Management bought 47 NCR Atleos shares in Q3 2026, an estimated $2.17K.
  • NCR Atleos made up ﹤0.01% of Geneos Wealth Management's portfolio in Q3 2026, its #2035 holding.
  • Geneos Wealth Management first reported a position in NCR Atleos in Q4 2024 and has held it in 8 quarters since.
  • 284 funds tracked by Wall St. Rank held NCR Atleos as of Q3 2026.

Based on Geneos Wealth Management's 13F filing for Q3 2026, filed 9 Nov 2026.